beta-D-Galp-(1->4)-alpha-D-Glcp-(1->6)-D-Glcp

Term ID

CHEBI:147983

Synonyms

(3R,4S,5S,6R)-6-[[(2S,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol
beta-D-galacto-hexopyranosyl-(1->4)-alpha-D-gluco-hexopyranosyl-(1->6)-D-gluco-hexopyranose
beta-D-galactopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->6)-D-glucopyranose
Gal(b1-4)Glc(a1-6)Glc

Definition

A trisaccharide consisting of β-D-galactopyranose, α-D-glucopyranose and D-glucopyranose residues joined in sequence by (1→4) and (1→6) glycosidic bonds.

References

glygen:G18792RR
glytoucan:G18792RR
kegg.glycan:G09224

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-alpha-D-Glcp-(1->6)-D-Glcp

Phenotype where environments contain beta-D-Galp-(1->4)-alpha-D-Glcp-(1->6)-D-Glcp

Phenotype modified by environments containing beta-D-Galp-(1->4)-alpha-D-Glcp-(1->6)-D-Glcp

Phenotype affecting beta-D-Galp-(1->4)-alpha-D-Glcp-(1->6)-D-Glcp

Human Disease Model